NO985695D0 - Formulering og fremgangsmÕte for Õ behandle kongrestiv hjerteinfarkt - Google Patents

Formulering og fremgangsmÕte for Õ behandle kongrestiv hjerteinfarkt

Info

Publication number
NO985695D0
NO985695D0 NO985695A NO985695A NO985695D0 NO 985695 D0 NO985695 D0 NO 985695D0 NO 985695 A NO985695 A NO 985695A NO 985695 A NO985695 A NO 985695A NO 985695 D0 NO985695 D0 NO 985695D0
Authority
NO
Norway
Prior art keywords
formulation
procedure
congestive heart
heart attack
treating congestive
Prior art date
Application number
NO985695A
Other languages
English (en)
Other versions
NO985695L (no
Inventor
John L Mcnay
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO985695D0 publication Critical patent/NO985695D0/no
Publication of NO985695L publication Critical patent/NO985695L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO985695A 1996-06-06 1998-12-04 Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt NO985695L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65946396A 1996-06-06 1996-06-06
PCT/US1997/009914 WO1997046241A1 (en) 1996-06-06 1997-06-05 Formulation and method for treating congestive heart failure

Publications (2)

Publication Number Publication Date
NO985695D0 true NO985695D0 (no) 1998-12-04
NO985695L NO985695L (no) 1999-02-04

Family

ID=24645503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985695A NO985695L (no) 1996-06-06 1998-12-04 Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt

Country Status (17)

Country Link
EP (1) EP0914128A1 (no)
JP (1) JP2000511906A (no)
KR (1) KR20000016406A (no)
CN (1) CN1226166A (no)
AU (1) AU3233197A (no)
BR (1) BR9709546A (no)
CA (1) CA2256720A1 (no)
CZ (1) CZ397698A3 (no)
EA (1) EA199900006A1 (no)
HU (1) HUP0003885A2 (no)
IL (1) IL126966A0 (no)
NO (1) NO985695L (no)
PL (1) PL330637A1 (no)
TR (1) TR199802496T2 (no)
WO (1) WO1997046241A1 (no)
YU (1) YU55998A (no)
ZA (1) ZA974978B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19815411A1 (de) * 1998-04-06 1999-10-07 Solvay Pharm Gmbh Thermogenese stimulierend wirksame Arzneimittel
WO2000044355A1 (en) * 1999-01-29 2000-08-03 Eli Lilly And Company Moxonidine salts
AU774855B2 (en) * 1999-02-01 2004-07-08 Abbott Laboratories Gmbh Use of moxonidine for postmyocardial infarction treatment
ATE487712T1 (de) * 2006-08-31 2010-11-15 Chemagis Ltd Verwendung der monoxidinssalze zur reinigung von monoxidin
KR100812287B1 (ko) * 2007-01-03 2008-03-13 주식회사 챠콜코리아 내면에 반사층을 갖는 신호등 갓

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE3617158C2 (de) * 1986-05-22 1994-10-06 Lohmann Therapie Syst Lts Transdermales Arzneimittel
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
CA2182851A1 (en) * 1995-08-15 1997-02-16 August Masaru Watanabe Method for treating substance abuse withdrawal

Also Published As

Publication number Publication date
EA199900006A1 (ru) 1999-06-24
BR9709546A (pt) 1999-08-10
IL126966A0 (en) 1999-09-22
EP0914128A1 (en) 1999-05-12
HUP0003885A2 (hu) 2001-04-28
KR20000016406A (ko) 2000-03-25
CN1226166A (zh) 1999-08-18
JP2000511906A (ja) 2000-09-12
AU3233197A (en) 1998-01-05
PL330637A1 (en) 1999-05-24
CA2256720A1 (en) 1997-12-11
YU55998A (en) 1999-11-22
NO985695L (no) 1999-02-04
WO1997046241A1 (en) 1997-12-11
ZA974978B (en) 1998-12-07
CZ397698A3 (cs) 1999-05-12
TR199802496T2 (xx) 1999-02-22

Similar Documents

Publication Publication Date Title
FI973074A0 (fi) Leivontamenetelmä ja siihen liittyvä laite
NO984431L (no) FremgangsmÕte for behandling av smerte
NO983387L (no) Oksygeneringsapparat, fremgangsmåte ved oksygenering av vann og anvendelse derav
NO992237D0 (no) Vannbehandlingsprosess
DE69623437D1 (de) Wasserbehandlungsapparat
ITBO960079A0 (it) Apparecchiatura per il trattamento del terreno
ID17194A (id) Metode pengobatan inflamasi
DK91793A (da) Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf
NO20005433D0 (no) Human BMP-7-promotor og metode for Õ utforske benrelatert stoff ved Õ bruke det samme
NO972426D0 (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
DE69718808T2 (de) Plasmabehandlungsmethode
NO974153L (no) Anordning for behandling av krumme flater
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO993030D0 (no) FremgangsmÕte og system for Õ skaffe forbindelser
NO985695D0 (no) Formulering og fremgangsmÕte for Õ behandle kongrestiv hjerteinfarkt
DE69717846T2 (de) Behandlungsverfahren von laktamen
NO983215D0 (no) Sammensetninger for behandling av hudpÕvirkninger og fremgangsmaate for dens fremstilling
ID16924A (id) Metode perlakuan poliolefin
EE9600113A (et) Reovee puhastamise meetod ja seade
NO984906D0 (no) Vannbehandling
DE29612101U1 (de) Behandlungsliege
FI972888A (fi) Vedenkäsittelymenetelmä sekä menettelyssä käytettävä laitteisto ja kemikaalibriketti
NO20005432D0 (no) Human BMP-4-promotor og metode for Õ utforske benrelatert stoff ved Õ bruke det samme
KR950027501U (ko) 수처리 장치
KR970058391U (ko) 마이크로-펄 열처리 장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application